% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • eddavis2011 eddavis2011 Sep 29, 2013 4:41 PM Flag

    $28M Market Cap Is Too Low

    There are numerous bio-techs with less potential than AMBS with market caps that are many times higher.

    LymPro and MANF could be worth billions.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Its funny about Biomed value. Something has to happen to small promising Bio-meds before they transition from next to no value to massive value. Jason Napodano says for AMBS it is money. Once we have enough money that we can move LymPro and several MANF indications forward without needing Big Pharma Partnership money...the more value we become to Big Pharma. It's the "forbidden fruit" thing, you always want what you can't get. The harder to get Gerald is able to play, the more intensely Big Pharma will pursue him. I think Gerald is benefited by having some powerful people with a lot of experience around him giving him coaching. They know the way to the "Promised Land."

0.33+0.04(+13.79%)Feb 5 3:59 PMEST